TCT 2024 | Distal Radial vs Transradial Approach in STEMI Patients

The transradial approach (TRA) has been recommended for patients with ST-elevation myocardial infarction (STEMI) for reduced bleeding complications and mortality. However, evidence in support of the use of distal radial access (DRA) in these patients is limited. This study aimed at showing DRA puncture success rate would be no inferior than that of TRA.

Primary endpoint was puncture success rate. Secondary endpoints included coronary angiography and angioplasty success rates, bleeding complications, puncture, procedural, hemostasis and fluoroscopy time, contrast volume, and major adverse cardiovascular events (MACE), including all-cause death, myocardial infarction, and revascularization.

A total of 354 patients were randomized: 174 were assigned to DRA and 175 to TRA. Puncture success rate resulted 94.3% for DRA patients vs. 96.1% for TRA. 

Read also: STEACS and the Use of Bivalirudin vs. Heparin: In Search of BRIGHT-4 Outcomes.

Access site bleeding was more frequent among TRA patients vs. DRA, though not statistically significant. No significant differences were found when looking at secondary endpoints.

Conclusión  

In this multicenter study of STEMI patients, DRA vs TRA puncture success rate resulted inconclusive in both intention-to-treat and per-protocol analyses. However, DRA was shown non-inferior based on treatment. Large-scale studies are needed to confirm these findings.

Original Title: Comparison of Puncture Success Rate between Distal Radial Access and Transradial Access in Patients with ST-elevation Myocardial Infarction.

Reference: Jun-Won LEE, MD, PhD et al TCT 2024.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....